CD14 -159 C>T Gene Polymorphism with Increased Risk of Tuberculosis: Evidence from a Meta-Analysis

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Areeshi, M Y ^a   Mandal, Raju K ^b   Panda, Aditya K ^c   Bisht, Shekhar C ^d   Haque, Shafiul ^e  

^a JAZAN UNIVERSITY   (Saudi Arabia)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^c INSTITUTE OF LIFE SCIENCES   (India)

^d H N B GARHWAL UNIVERSITY   (India)

^e JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; THYMINE;

ALLELE; ARTICLE; CD14 GENE; CD159 GENE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE; GENETIC MODEL; GENETIC SUSCEPTIBILITY; HOMOZYGOSITY; HUMAN; INNATE IMMUNITY; PROMOTER REGION; QUALITY CONTROL; TUBERCULOSIS;

ALLELES; ANTIGENS, CD14; CASE-CONTROL STUDIES; DATABASES, BIBLIOGRAPHIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, GENETIC; MULTIGENE FAMILY; MYCOBACTERIUM TUBERCULOSIS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 84878546836     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064747     Document Type: Article

References (35)

1. King KY, Lew JD, Ha NP, Lin JS, Ma X, et al. (2011) Polymorphic allele of human IRGM1 is associated with susceptibility to tuberculosis in African Americans. PLoS One 6: e16317.
2. Stein CM, (2011) Genetic epidemiology of tuberculosis susceptibility: impact of study design. PLoS Pathog 7: e1001189.
3. Cooke GS, Hill AV, (2001) Genetics of susceptibility to human infectious disease. Nat Rev Genet 2: 967-977.
4. Thye T, Vannberg FO, Wong SH, Owusu-Dabo E, Osei I, et al. (2010) Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet 42: 739-741.
5. Triantafilou M, Triantafilou K, (2002) Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 23: 301-304.
6. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC, (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433.
7. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, (1998) Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392: 505-509.
8. Haziot A, Chen S, Ferrero E, Low MG, Silber R, et al. (1988) The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 141: 547-552.
9. Ayaslioglu E, Tekeli E, Birengel S, (2005) Significant elevation of serum soluble CD14 levels in patients with brucellosis. Jpn J Infect Dis 58: 11-14.
10. Juffermans NP, Verbon A, van Deventer SJ, Buurman WA, van Deutekom H, et al. (1998) Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis. J Infect Dis 178: 1839-1842.
11. Rosas-Taraco AG, Revol A, Salinas-Carmona MC, Rendon A, Caballero-Olin G, et al. (2007) CD14 C(-159)T polymorphism is a risk factor for development of pulmonary tuberculosis. J Infect Dis 196: 1698-1706.
12. LeVan TD, Bloom JW, Bailey TJ, Karp CL, Halonen M, et al. (2001) A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 167: 5838-5844.
13. Alavi-Naini R, Salimi S, Sharifi-Mood B, Davoodikia AA, Moody B, et al. (2012) Association between the CD14 gene C-159T polymorphism and serum soluble CD14 with pulmonary tuberculosis. Int J Tuberc Lung Dis 16: 1383-1387.
14. Ayaslioglu E, Kalpaklioglu F, Kavut AB, Erturk A, Capan N, et al. (2012) The role of CD14 gene promoter polymorphism in tuberculosis susceptibility. J Microbiol Immunol Infect doi:pii: S1684-1182(12)00109-0.
15. Zhao MY, Xue Y, Zhao ZQ, Li FJ, Fan DP, et al. (2012) Association of CD14 G(-1145)A and C(-159)T polymorphisms with reduced risk for tuberculosis in a Chinese Han population. Genet Mol Res 11: 3425-3431.
16. Kang YA, Lee HW, Kim YW, Han SK, Shim YS, et al. (2009) Association between the -159C/T CD14 gene polymorphism and tuberculosis in a Korean population. FEMS Immunol Med Microbiol 57: 229-235.
17. Druszczyńska M, Strapagiel D, Kwiatkowska S, Kowalewicz-Kulbat M, Rózalska B, et al. (2006) Tuberculosis bacilli still posing a threat. Polymorphism of genes regulating anti-mycobacterial properties of macrophages. Pol J Microbiol 55: 7-12.
18. Pacheco E, Fonseca C, Montes C, Zabaleta J, García LF, et al. (2004) CD14 gene promoter polymorphism in different clinical forms of tuberculosis. FEMS Immunol Med Microbiol 40: 207-213.
19. Wu R, Li B, (1999) A multiplicative-epistatic model for analyzing interspecific differences in outcrossing species. Biometrics 55: 355-365.
20. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
21. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
23. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
24. Bellamy R, (2003) Susceptibility to mycobacterial infections: the importance of host genetics. Genes Immun 4: 4-11.
25. Hoheisel G, Zheng L, Teschler H, Striz I, Costabel U, (1995) Increased soluble CD14 levels in BAL fluid in pulmonary tuberculosis. Chest 108: 1614-1616.
26. Juffermans NP, Verbon A, van Deventer SJ, Buurman WA, van Deutekom H, et al. (1998) Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis. J Infect Dis 178: 1839-1842.
27. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, et al. (1999) A Polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol. 20: 976-983.
28. Egger M, Smith GD, Phillips AN, (1997) Meta-analysis: principles and procedures. BMJ 315: 1533-1537.
29. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
30. Chao YC, Chu HC, Chang WK, Huang HH, Hsieh TY, (2005) CD14 promoter polymorphism in Chinese alcoholic patients with cirrhosis of liver and acute pancreatitis. World J Gastroenterol 11: 6043-6048.
31. Pugin J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, et al. (1993) Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. P Natl Acad Sci USA 90: 2744-2748.
32. Peterson PK, Gekker G, Hu S, Sheng WS, Anderson WR, et al. (1995) CD14 receptor-mediated uptake of non-opsonized Mycobacterium tuberculosis by human microglia. Infect Immun 63: 1598-1602.
33. Shams H, Wizel B, Lakey DL, Samten B, Vankayalapati R, et al. (2003) The CD14 receptor does not mediate entry of Mycobacterium tuberculosis into human mononuclear phagocytes. FEMS Immunol Med Microbiol 36: 63-69.
34. Vercelli D, Baldini M, Martinez F, (2001) The monocyte/IgE connection: may polymorphisms in the CD14 gene teach us about IgE regulation? Int Arch Allergy Immunol 124: 20-24.
35. Kang HJ, Choi YM, Chae SW, Woo JS, Hwang SJ, et al. (2006) Polymorphism of the CD14 gene in perennial allergic rhinitis. Int J Pediatr Otorhinolaryngol 70: 2081-2085.